growing

Infrastructure for Antimicrobial Stewardship Decision Support

AI system that monitors antibiotic usage, identifies stewardship opportunities, and recommends interventions to optimize antimicrobial therapy.

Last updated: February 2026Data current as of: February 2026

Analysis based on CMC Framework: 730 capabilities, 560+ vendors, 7 industries.

T3·Cross-system execution

Key Finding

Antimicrobial Stewardship Decision Support requires CMC Level 4 Formality for successful deployment. The typical pharmacy operations organization in Healthcare faces gaps in 2 of 6 infrastructure dimensions.

Structural Coherence Requirements

The structural coherence levels needed to deploy this capability.

Requirements are analytical estimates based on infrastructure analysis. Actual needs may vary by vendor and implementation.

Formality
L4
Capture
L4
Structure
L4
Accessibility
L4
Maintenance
L4
Integration
L3

Why These Levels

The reasoning behind each dimension requirement.

Formality: L4

Antimicrobial stewardship decision support requires machine-readable clinical logic: IF (culture result available AND empiric antibiotic covers cultured organism AND organism susceptible to narrower-spectrum agent) THEN recommend de-escalation. IDSA guidelines and facility antibiograms must be formalized as queryable rules, not PDF protocols. Duration thresholds, IV-to-PO conversion criteria, and C. difficile risk combinations must all be explicitly codified for the AI to generate real-time, actionable stewardship recommendations without pharmacist re-interpretation of every alert.

Capture: L4

Stewardship decision support requires automated capture of antibiotic order events, culture result finalization, susceptibility report release, dose administration confirmations, and renal function lab results as they occur in real-time workflows. Waiting for periodic data pulls means the system generates de-escalation recommendations hours after culture results are available—missing the optimal intervention window. CPOE and microbiology system events must stream to the stewardship engine automatically.

Structure: L4

The stewardship AI needs formal ontology: Antibiotic entities with spectrum classifications, Organism entities with susceptibility relationships, Patient entities with renal function and allergy attributes, and rule mappings (Organism.susceptibleTo.Antibiotic → de-escalation recommendation WITH conditions: Patient.RenalFunction, Patient.Allergy). Local antibiogram data must be structured as a formal resistance-probability matrix by unit and organism. Without this ontology, the system can't compute de-escalation appropriateness across the antibiotic-organism-patient triad.

Accessibility: L4

Stewardship decision support requires unified API access to CPOE (antibiotic orders), microbiology LIS (culture and sensitivity results), pharmacy (administration records and IV-to-PO eligibility), laboratory (renal function, inflammatory markers), and allergy records. These systems must be queried in aggregate to generate a complete stewardship picture per patient. A unified access layer enabling the AI to assemble patient-level antibiotic context from all sources in real-time is essential—fragmented access produces incomplete recommendations that miss contraindications.

Maintenance: L4

Stewardship logic must update when local antibiogram data changes (typically annually but with significant mid-year shifts in resistance patterns), when IDSA guidelines are revised, or when formulary changes add or remove antibiotic options. Near-real-time sync is required because local resistance patterns—the antibiogram—must reflect the most current organism susceptibilities to generate accurate de-escalation recommendations. Stale antibiogram data produces recommendations for antibiotics with rising local resistance rates.

Integration: L3

Antimicrobial stewardship requires API-based connections between CPOE, microbiology LIS, pharmacy dispensing, laboratory (renal function, CRP, procalcitonin), and EHR clinical documentation. These connections enable the system to correlate antibiotic orders with culture results, patient renal function, and administration history to produce stewardship alerts. The existing EHR-to-pharmacy-to-lab integration infrastructure in healthcare operations supports this, though external infection control databases and regional resistance networks aren't yet required.

What Must Be In Place

Concrete structural preconditions — what must exist before this capability operates reliably.

Primary Structural Lever

How explicitly business rules and processes are documented

The structural lever that most constrains deployment of this capability.

How explicitly business rules and processes are documented

  • Fully machine-readable antimicrobial stewardship program policies encoding antibiotic selection criteria, de-escalation triggers, duration limits, and restricted-agent authorization pathways as version-controlled rule sets

Whether operational knowledge is systematically recorded

  • Near-real-time capture of antibiotic orders, culture and sensitivity results, pharmacokinetic monitoring events, and clinical outcome markers into structured audit trails with lineage

How data is organized into queryable, relational formats

  • Multi-dimensional classification of antimicrobial agents by drug class, spectrum, resistance risk tier, and stewardship priority linked to pathogen ontologies

Whether systems expose data through programmatic interfaces

  • API-first access layer federating queries across microbiology, pharmacy, and clinical systems to surface real-time susceptibility and utilization data to the decision engine

How frequently and reliably information is kept current

  • Continuous monitoring of local antibiogram data and resistance pattern drift with automated alerts when empirical therapy recommendations deviate from current susceptibility profiles

Whether systems share data bidirectionally

  • Standard middleware layer connecting microbiology laboratory information systems, pharmacy dispensing, and prescriber order entry into a unified data flow for the stewardship engine

Common Misdiagnosis

Programs invest in dashboards displaying utilization metrics while stewardship intervention criteria remain in narrative policy documents — the AI engine cannot generate actionable recommendations without machine-readable de-escalation and restriction rules.

Recommended Sequence

Start with encoding stewardship policies as machine-readable rule sets before any A or I work, since federated data access only produces value when the decision engine has explicit clinical criteria to apply against retrieved results.

Gap from Pharmacy Operations Capacity Profile

How the typical pharmacy operations function compares to what this capability requires.

Pharmacy Operations Capacity Profile
Required Capacity
Formality
L4
L4
READY
Capture
L4
L4
READY
Structure
L4
L4
READY
Accessibility
L3
L4
STRETCH
Maintenance
L3
L4
STRETCH
Integration
L3
L3
READY

More in Pharmacy Operations

Frequently Asked Questions

What infrastructure does Antimicrobial Stewardship Decision Support need?

Antimicrobial Stewardship Decision Support requires the following CMC levels: Formality L4, Capture L4, Structure L4, Accessibility L4, Maintenance L4, Integration L3. These represent minimum organizational infrastructure for successful deployment.

Which industries are ready for Antimicrobial Stewardship Decision Support?

Based on CMC analysis, the typical Healthcare pharmacy operations organization is not structurally blocked from deploying Antimicrobial Stewardship Decision Support. 2 dimensions require work.

Ready to Deploy Antimicrobial Stewardship Decision Support?

Check what your infrastructure can support. Add to your path and build your roadmap.